Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

More On VRX.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Valeant Pharmaceuticals International, Inc. (VRX.TO)

-Toronto
137.42 Up 3.17(2.36%) 3:59PM EDT
Prev Close:134.25
Open:135.02
Bid:135.19
Ask:137.44
1y Target Est:N/A
Beta:N/A
Next Earnings Date:31-Jul-14VRX.TO Earnings announcement
Day's Range:135.02 - 138.30
52wk Range:93.98 - 170.45
Volume:276,809
Avg Vol (3m):322,241
Market Cap:46.07B
P/E (ttm):N/A
EPS (ttm):-2.63
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

» More Headlines for VRX.TO

Key Statistics

Forward P/E (1 yr):12.95
P/S (ttm):6.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.74
Quarterly EPS Est (Jun-14) :2.05
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):0.83

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback